After-Hours Movers 7/29: NAVR, AMKR, CBT, EGHT, QCOR Higher; MTSN, AKAM, CTV, GMR, SYMC Lower

July 29, 2009 6:06 PM EDT

Navarre (Nasdaq: NAVR) 12.5% HIGHER; reports Q1 EPS of $0.11, 11 cents better than the analyst estimate of $0.00. Revenue for the quarter was $134.3 million, versus the consensus of $119.01 million. Sees FY10 revs $525M to $575M versus consensus of $568 million. Raises EBITDA range to $21M to $24M.

Mattson Technology (Nasdaq: MTSN) 12.5% LOWER; reports Q2 EPS of ($0.40), 1 cent better than the analyst estimate of ($0.41). Revenue for the quarter was $8.1 million, versus the consensus of $10.61 million.

Akamai Technologies Inc. (Nasdaq: AKAM) 11.7% LOWER; reports Q2 EPS of $0.40, 1 cent lower than the analyst estimate of $0.41. Revenue for the quarter was $204.6 million, versus the consensus of $210.99 million.

CommScope (NYSE: CTV) 10.8% LOWER; reports Q2 EPS of $0.67, 6 cents better than the analyst estimate of $0.61. Revenue for the quarter was $784 million, versus the consensus of $835.47 million. Sees Q3 revs $750M to $800M versus $877.95.

General Maritime Corporation (NYSE: GMR) 10.3% LOWER; reports Q2 EPS of $0.14 versus the analyst estimate of $0.18. Revenue for the quarter was $80.2 million, versus the consensus of $74.18 million.

Amkor Technology, Inc. (Nasdaq: AMKR) 7.8% HIGHER; reports Q2 EPS of $0.03, 4 cents better than the analyst estimate of ($0.01). Revenue for the quarter was $507 million, versus the consensus of $471.54 million.

Symantec (Nasdaq: SYMC) 7.4% LOWER; reports Q1 EPS of $0.34, 1 cent below the analyst estimate of $0.35. Revenue for the quarter was $1.44 billion, versus the consensus of $1.49 billion. Sees Q2 EPS 32c 34c versus 36 cents consensus. Sees Q2 revs $1.395B to $1.45B versus $1.5 consensus.

Green Mountain Coffee Roasters, Inc. (Nasdaq: GMCR) 7.3% LOWER; reports Q3 EPS of $0.36, 8 cents better than the analyst estimate of $0.28. Revenue for the quarter was $190.5 million, versus the consensus of $193.99 million. Raises FY09 EPS guidance from $0.98-$1.02 to $1.10-$1.14, versus the consensus of $1.03. GAAP FY10 EPS of $1.70-$1.80.

FMC Corporation (NYSE: FMC) 6.7% LOWER; reports Q2 EPS of $1.10, 5 cents below the analyst estimate of $1.15. FMC Corporation sees Q3 EPS of $0.85-$0.95, versus the consensus of $1.15. FMC Corporation sees FY EPS of $4-$4.20, versus the consensus of $4.60.

Teekay Offshore Partners L.P. (NYSE: TOO) 6.6% LOWER; plans to offer 6,500,000 common units, representing limited partner interests, in a public offering. Teekay Offshore expects to grant the underwriters a 30-day option to purchase an additional 975,000 common units to cover over-allotments, if any. The Partnership expects to use the net proceeds from the public offering to repay amounts outstanding on one of its revolving credit facilities.

Cabot (NYSE: CBT) 6.2% HIGHER; reports Q3 EPS of $0.06, ex-items, or a loss of $0.19 on an unadjusted basis, versus the analyst estimate of ($0.21). Revenue for the quarter was $511 million, versus the consensus of $553.33 million.

MDRNA, Inc. (Nasdaq: MRNA) 5.6% LOWER; reports Q2 loss of $0.21, versus a loss of $.0.48 last year. Revenue for the quarter was $309K, versus $754K last year.

8x8, Inc. (Nasdaq: EGHT) 5.4% HIGHER; reports Q2 EPS of $0.01, 1 cent better than the analyst estimate of $0.00. Revenue for the quarter was $15.6 million, versus the consensus of $15.29 million. Announces $2 million buyback.

Digital River, Inc. (Nasdaq: DRIV) 5.3% LOWER; reports Q2 EPS of $0.44, 3 cents better than the analyst estimate of $0.41. Revenue for the quarter was $96.6 million, versus the consensus of $96.50 million. Sees Q3 EPS of $0.38-$0.41, versus the consensus of $0.45 and revs of $96.5-$98.5 million, versus the Street estimate of $97.8 million.

Questcor Pharmaceuticals, Inc. (Nasdaq: QCOR) 4.9% HIGHER; reports Q2 EPS of $0.14, 1 cent better than the analyst estimate of $0.13. Revenue for the quarter was $48.6 million, versus the consensus of $27.33 million.

Flowserve Corporation (NYSE: FLS) 4.6% HIGHER; reports Q2 EPS of $1.92, versus the analyst estimate of $1.79. Revenue for the quarter was $1.09 billion, versus the consensus of $1.17 billion. Sees Fy09 EPS of $7.15-$7.75, versus the consensus of $7.25.

Cytokinetics, Inc. (Nasdaq: CYTK) 4.2% HIGHER; reports Q2 EPS of $0.98, versus the analyst estimate of $0.50. Revenue for the quarter was $71.9 million, versus the consensus of $43.65 million.

Flextronics (Nasdaq: FLEX) 4% LOWER; reports Q1 EPS of $0.08, 2 cents better than the analyst estimate of $0.06. Revenue for the quarter was $5.8 billion, versus the consensus of $5.55 billion. Sees Q2 EPS 7c to 11c versus consensus of 8c. Sees Q2 revenue $5.2B to $6B versus consensus $5.85B.

Visa Inc. (NYSE: V) 1% LOWER; reports Q3 EPS of $0.97 GAAP, $0.67 ex-items versus the analyst estimate of $0.64. Revenue for the quarter was $1.6 billion, versus the consensus of $1.64 billion.

To get this report daily, visit http://www.streetinsider.com/entities/After-Hours+Movers.

Related Categories

Special Reports

Stocks Mentioned

Related Entities

• After-Hours Movers

Add Your Comment

Name

Subject

Body

Verification can't see the text?
click here to refresh the image.
what's this?